Atlas Trials

SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma

Clinical trial NCT02303262 · COMPLETED

Trial details

NCT number
NCT02303262
Sponsor
Sarcoma Alliance for Research through Collaboration
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Leiomyosarcoma
Start date
2015-11-12
Primary completion
2016-12-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.